Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Gabor Marth, Mark Yandell, George Scangos


Gabor Marth and Mark Yandell are co-directors of the newly launched USTAR Center for Genetic Discovery, which will be housed at the University of Utah School of Medicine. The center will develop and commercialize computational methods for the discovery of relationships between genes and disease.

Marth, who will also serve as a professor of genetics at USTAR, was previously an associate professor of biology at Boston College. He holds a PhD from Washington University in St. Louis.

Yandell has been a faculty member at the University of Utah's Eccles Institute of Human Genetics since 2004. Prior to that, he was a senior scientist with Howard Hughes Medical Institute at the University of California, Berkeley. He holds a PhD from the University of Colorado, Boulder.

Agilent has appointed Biogen Idec CEO George Scangos to its board of directors, effective in September.

Prior to Biogen, Scangos served as president and CEO of Exelixis, a drug discovery and development company. He was previously president of Bayer Biotechnology.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.